Mint Business News - Official Channel
✔
112K subscribers
11.3K photos
510 videos
7 files
21.6K links
News and analysis from the world of business and finance.

For more, visit
www.livemint.com
Download Telegram
Mounjaro's rapid rise is a testament to the growing demand for effective diabetes and obesity treatments in India, where around 101 million people – 11.4 percent of the country's population – live with diabetes, as per a 2023 Lancet study.

But what is the drug and what are the side impacts? Is it even worth it?
WATCH: https://www.youtube.com/watch?v=ZsMBkxuADUw
❤2🤔1
📈 MARKETS OPEN FLAT WITH A POSITIVE BIAS
Sensex starts higher, up 257 pts at 83,473, while Nifty holds steady around 25,492.
Investors await global cues and key earnings later in the day.

Track all market updates here 👇
https://www.livemint.com/market
❤5